-
Report Details
More...Snapshot
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017 -
Table Of Content
More...
Table of Content
1 Industry Overview
1.1 Capecitabine Industry
1.1.1 Overview
1.1.2 Development of Capecitabine
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Capecitabine Market by Type
3.1 Segment Overview
3.1.1 500 mg -
Inquiry Before Buying
-
Request Sample
